In 2019, upwards of 1.2 million individuals perished from drug-resistant illnesses. But all of that could change with the advent of the ‘game-changing’ antibiotic that could potentially save millions, according to a new study.
In a recent study published on Tuesday, UK scientists lauded a “game-changing” antibiotic that could rescue millions of people globally from drug-resistant superbugs.
The discovery was made by a group of scientists collaborating with the University of Lincoln to generate novel versions of the chemical teixobactin that efficiently killed germs without harming the tissue of the mammals that it was tested upon.
The researchers used a mouse experiment to effectively eradicate a superbug identified as MRSA, which had previously remained impervious to antibiotics.
“Our ultimate goal is to have a number of viable drugs from our modular synthetic teixobactin platform which can be used as a ‘last line of defence’ against superbugs to save lives currently lost due to AMR,” Dr Ishwar Singh, who led the research, said.
Subscribe to GreatGameIndia
Teixobactin was earlier heralded as a “game-changing” antibiotic after a 2015 study, but the current research was able to generate “synthetic” classes of the medicine, enabling for simpler global dissemination, according to the researchers.
Antibiotic resistance is causing “one of the most dangerous global crises facing the modern world today,” according to Public Health England, which fears that antibiotics will someday be unable to cure major infections.
In 2019, upwards of 1.2 million individuals perished from drug-resistant illnesses, according to the Global Research on Antimicrobial Resistance survey issued in The Lancet in January. In the research of 204 nations and regions, an additional 4.95 million fatalities were linked to antibiotic resistance.
According to a review on antimicrobial resistance (AMR) commissioned by the UK government, an additional 10 million people will die annually from drug-resistant diseases by 2050.